Arcutis Biotherapeutics Inc (ARQT) current stock price is $2.07. During the last trading session, the stock soared, reaching $2.335 after opening at $2.12. The stock’s lowest point was $2.03 before it closed at $2.04.
The stock market performance of Arcutis Biotherapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $19.10 on 11/21/22, while the lowest price during the same time frame was $1.80, recorded on 11/10/23.
52-week price history of ARQT Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Arcutis Biotherapeutics Inc’s current trading price is -89.16% away from its 52-week high, while its distance from the 52-week low is 15.00%. The stock’s price range during this period has fluctuated between $1.80 and $19.10. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 7.18 million for the day, which was evidently higher than the average daily volume of 2.15 million over the last three months.
Financial Performance and Market Capitalization
Arcutis Biotherapeutics Inc (ARQT) has experienced a quarterly decline of -72.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 195.37M and boasts a workforce of 268 employees.
Analysts’ Ratings For Arcutis Biotherapeutics Inc
As of right now, 6 analysts are rating Arcutis Biotherapeutics Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.53, with a change in price of -6.26. Similarly, Arcutis Biotherapeutics Inc recorded 1,744,629 in trading volume during the last 100 days, posting a change of -75.15%.
ARQT Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ARQT stands at 4.39. Similarly, the long-term debt-to-equity ratio is also 4.37.
ARQT Stock Stochastic Average
The raw stochastic average for Arcutis Biotherapeutics Inc over the last 50 days is presently at 4.14%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 35.06%. Further, the company’s Stochastic %K and %D values for the last 20 days were 28.57% and 23.49%, respectively.
ARQT Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -86.01%. However, over the last six months, the performance has been stronger by -78.96%. The price of ARQT decreased -16.02% over the last 30 days. And in the last five days, it has fallen by -1.90%.